UPDATED Sep 11, 2025
Discover small cap Global Pharmaceuticals & Biotech companies from around the world. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
LIVEN | PK₨65.09 | 2.7% | 105.3% | PK₨6.1b | n/a | PE56.2x | n/a | n/a | ||
CING | US$3.93 | 3.7% | -33.8% | US$21.5m | US$27.71 | PB4x | E57.1% | n/a | ||
QTTB | US$1.88 | 13.3% | -95.9% | US$21.7m | US$12.00 | PE-0.4x | E-36.9% | n/a | ||
HF00 | €0.33 | 2.5% | 63.0% | €18.7m | n/a | PB0.7x | n/a | n/a | ||
A373110 | ₩2,820.00 | 1.8% | -62.9% | ₩30.5b | n/a | PS20.8x | n/a | n/a | ||
ASBP | US$0.45 | -17.1% | -96.1% | US$22.0m | n/a | PE-1.2x | n/a | n/a | ||
PPCB | US$1.98 | 0% | -90.6% | US$22.1m | n/a | PB1.4x | n/a | n/a | ||
524654 | ₹194.95 | -6.3% | -42.4% | ₹2.0b | n/a | PS1.2x | n/a | 0% | ||
EMD | AU$0.047 | -4.1% | 6.8% | AU$33.2m | n/a | PS22.4x | n/a | n/a | ||
SABS | US$2.12 | -6.2% | -23.3% | US$22.2m | US$9.20 | PS192.4x | E-17.5% | n/a | ||
LIFE | ₽4.51 | 0% | -23.5% | ₽1.4b | n/a | PS3x | n/a | n/a | ||
CRIS | US$1.82 | 6.4% | -63.5% | US$22.4m | US$16.33 | PS2x | E16.5% | n/a | ||
PASG | US$6.97 | -0.4% | -53.3% | US$22.4m | US$59.25 | PB0.6x | E46.1% | n/a | ||
6549 | NT$8.12 | -2.8% | -20.8% | NT$680.2m | n/a | PB7.9x | n/a | n/a | ||
A343090 | ₩1,761.00 | 5.5% | -19.0% | ₩31.3b | n/a | n/a | n/a | n/a | ||
1498 | HK$0.45 | 1.1% | -30.8% | HK$175.8m | n/a | PB1.7x | n/a | 0% | ||
LIXT | US$5.27 | 17.9% | 163.5% | US$22.6m | n/a | PB36.9x | n/a | n/a | ||
MVIR | SEK 1.88 | -3.8% | -35.5% | SEK 210.7m | SEK 18.71 | PS52.9x | E-2.2% | n/a | ||
4884 | JP¥490.00 | -1.4% | -42.4% | JP¥3.3b | n/a | PS46.2x | n/a | n/a | ||
ALPA | ₹95.03 | -0.04% | -20.4% | ₹2.0b | n/a | PE7.6x | n/a | n/a | ||
FBLG | US$0.56 | -4.9% | -82.1% | US$22.8m | US$10.25 | PB27.5x | E-26.1% | n/a | ||
SOFTX | NOK 0.10 | -12.3% | 426.3% | NOK 225.5m | n/a | PS24.2x | n/a | n/a | ||
GDTC | US$2.01 | 5.8% | 34.9% | US$22.9m | n/a | PS59x | n/a | n/a | ||
CLCS | US$0.47 | 14.6% | 23.7% | US$22.9m | n/a | PE-3.5x | n/a | n/a |